Waldmann, T.A.a , Conlon, K.C.a , Stewart, D.M.a , Worthy, T.Y.A.a , Janik, J.E.a , Fleisher, T.A.b , Albert, P.S.c , Figg, W.D.d , Spencer, S.D.e , Raffeld, M.f , Decker, J.R.a , Goldman, C.K.a , Bryant, B.R.a , Petrus, M.N.a , Creekmore, S.P.g , Morris, J.C.a h Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia

导出原文传递

翻译打印收藏纠错

作者： Waldmann,T.A. ^[1] ; Conlon,K.C. ^[2] ; Stewart,D.M. ^[3] ; Worthy,T.Y.A. ^[4] ; Janik,J.E. ^[5] ; Fleisher,T.A. ^[6] ; Albert,P.S. ^[7] ; Figg,W.D. ; Spencer,S.D. ; Raffeld,M. ; Decker,J.R. ; Goldman,C.K. ; Bryant,B.R. ; Petrus,M.N. ; Creekmore,S.P. ; Morris,J.C.

作者单位： Laboratory of Pathology, Center for Cancer Research, NIH, Bethesda, MD, United States ^[1] Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, Bethesda, MD ^[2] Biological Resources Branch, Developmental Therapeutics Program, NIH, Frederick, MD, United States ^[3] Medical Oncology Branch, Center for Cancer Research, NIH, Bethesda, MD, United States ^[4] Clinical Pharmacology Program, SAIC-Frederick Inc, NCI, Frederick, MD, United States ^[5] Metabolism Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes ^[6] Biostatistics and Bioinformatics Branch, National Institute of Child Health and Human Development ^[7]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交